References and Notes
1
Gilman H.
Speeter M.
J. Am. Chem. Soc.
1943,
65:
2255
2a
Singh GS.
Tetrahedron
2003,
59:
7631
2b
Enantioselective Synthesis of β-Amino Acids
2nd ed.:
Juaristi E.
Soloshonok VA.
Wiley-VCH;
Hoboken:
2005.
3a
Magriotis PA.
Angew. Chem. Int. Ed.
2001,
40:
4377
3b
Ojima I.
Delaloge F.
Chem. Soc. Rev.
1997,
26:
377
3c
Ojima I.
Acc. Chem. Res.
1995,
28:
383
3d
Chemistry and Biology of β-Lactam Antibiotics
Vol. 1-3:
Morin RB.
Gorman M.
Academic Press;
New York:
1982.
3e
Dürckheimer W.
Blumbach J.
Latrell R.
Scheunemann KH.
Angew. Chem., Int. Ed. Engl.
1985,
24:
180
3f
Nagahara T.
Kametani T.
Heterocycles
1987,
25:
729
3g
The Chemistry of β-Lactams
Page MI.
Chapman and Hall;
London:
1992.
4a
Alcaide B.
Almendros P.
Curr. Med. Chem.
2004,
11:
1921
4b
Deshmukh ARAS.
Bhawal BM.
Krishnaswamy D.
Govande VV.
Shinkre BA.
Jayanthi A.
Curr. Med. Chem.
2004,
11:
1889
4c
Alcaide B.
Almendros P.
Synlett
2002,
381
4d
Palomo C.
Aizpurua JM.
Ganboa I.
Oiarbide M.
Synlett
2001,
1813
4e
Alcaide B.
Almendros P.
Chem. Soc. Rev.
2001,
30:
226
5a
Hart DJ.
Ha DC.
Chem. Rev.
1989,
89:
1447
5b
Chen L.
Zhao G.
Ding Y.
Tetrahedron Lett.
2003,
44:
2611
6a
France S.
Weatherwax A.
Taggi AE.
Lectka T.
Acc. Chem. Res.
2004,
37:
592
6b
Tomioka K.
Fujieda H.
Hayashi S.
Hussein MA.
Kambara T.
Nomura Y.
Kanai M.
Koga K.
Chem. Commun.
1999,
715
7
Jian SZ.
Ma C.
Wang YG.
Synthesis
2005,
725
8
Seki M.
Miyake T.
Izukawa T.
Ohmizu H.
Synthesis
1997,
47
9
Typical Procedure for the Synthesis of β-Lactams 3.
A mixture of carboximide 1 (1.0 mmol), imine 2 (1.2 mmol) and zinc dust (3 mmol) in THF (5 mL) was refluxed for 10-20 min, cooled to r.t., poured into H2O (5 mL), and then extracted with CH2Cl2 (3 × 5 mL). The combined extracts were washed with brine, dried over anhyd Na2SO4, and evaporated in vacuo. The residue was chromatographed through a silica gel column with hexane-EtOAc to give pure β-lactams 3 and chiral auxiliary 4.
(3
S
,4
R
)-4-(4-Chlorophenyl)-3-methyl-1-phenylazetidin-2-one (
3a): 1H NMR (500 MHz, CDCl3): δ = 1.51 (d, J = 7.4 Hz, 3 H), 3.16 (dq, J = 2.4, 7.4 Hz, 1 H, H-3), 4.61 (d, J = 2.4 Hz, 1 H, H-4), 7.06 (m, 1 H) 7.26-7.43 (m, 9 H). 13C NMR (125 MHz, CDCl3): δ = 13.35, 55.56, 62.97, 117.21, 123.99, 126.07, 128.69, 129.28, 129.38, 138.08, 138.20, 168.63. ESI-MS: m/z = 238 [M + H]+.
(3
S
,4
S
,
E
)-3-Ethyl-1-phenyl-4-styrylazetidin-2-one (
3j): 1H NMR (500 MHz, CDCl3): δ = 1.09 (t, J = 7.4 Hz, 3 H), 1.83 (m, 1 H), 1.94 (m, 1 H), 3.06 (m, 1 H, H-3), 4.33 (dd, J = 1.9, 8.4 Hz, 1 H, H-4), 6.30 (dd, J = 8.4, 15.9 Hz, 1 H), 6.78 (d, J = 15.9 Hz, 1 H), 7.03-7.50 (m, 10 H). 13C NMR (125 MHz, CDCl3): δ = 11.63, 21.85, 59.21, 60.04, 117.03, 123.93, 126.83, 127.67, 128.53, 128.95, 129.28, 133.84, 136.02, 138.56, 167.61. ESI-MS: m/z = 278 [M + H]+, 300 [M + Na]+, 577 [2 M + Na]+.
10
Cainelli G.
Panunzio M.
Bandini E.
Martelli G.
Spunta G.
Tetrahedron
1996,
52:
1685
11 CCDC 273640 contains the supplementary crystallographic data (excluding structure factors) for compound 3b. These data can be obtained free of charge via http://www.ccdc. cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44(1223)336033; or deposit@ccdc.cam.ac.uk].